Background: The aims of assessing urinary incontinence in women are to define the diagnosis, exclude other pathology and guide management. Treatment can be initiated when urinary incontinence is categorised as stress, urge or mixed incontinence. Once conservative measures have been exhausted, the management of stress incontinence is largely surgical, while that of urge urinary incontinence is largely medical.
Objective: This article discusses the clinical assessment of urinary incontinence in women with emphasis on the primary care assessment and indications for specialist referral.
Discussion: History taking is the cornerstone of urinary incontinence assessment and in combination with physical examination allows categorisation of patients into stress, urge or mixed urinary incontinence. Basic assessment includes investigations such as urine testing, bladder residual volume measurement, and a bladder diary. Urodynamic testing is not required in all patients or before initiating conservative treatment. Indications for specialist referral and urodynamic testing are discussed.
Download full-text PDF |
Source |
---|
J Urol
January 2025
Division of Urology, Department of Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
Purpose: Urinary incontinence (UI) is common in nulliparous female elite athletes, but underlying pathophysiology is inadequately understood. We examined urinary symptoms and associated pelvic floor anatomy and function in this population, hypothesizing that athletes with UI would exhibit pelvic floor findings seen in older incontinent women (e.g.
View Article and Find Full Text PDFRev Esc Enferm USP
January 2025
Universidade Federal da Bahia, Escola de Enfermagem, Salvador, BA, Brasil.
Objective: To analyze self-care conditioning factors in women and men with urinary incontinence symptoms living with the Human T-Lymphotropic Virus Type 1.
Method: Qualitative study, based on the pragmatic phase of Praxis Model for Technology Development. Twelve women and five adult men living with Human T-Lymphotropic Virus Type 1, residing in Bahia, Brazil, participated in the study.
J Occup Health
January 2025
Department of Occupational and Environmental Health, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Japan.
Bromopropane was introduced commercially as an alternative to ozone-depleting and global warming solvents. The identification of 1-bromopropane neurotoxicity in animal experiments was followed by reports of human cases of 1-bromopropane toxicity. In humans, the most common clinical features of 1-bromopropane neurotoxicity are decreased sensation, weakness in extremities, and walking difficulties.
View Article and Find Full Text PDFUrogynecology (Phila)
January 2025
From the Division of Urogynecology, Department of OB/GYN, Harbor-UCLA Medical Center, Torrance, CA.
Importance: Stress urinary incontinence (SUI) affects approximately 50% of women. There are limited data regarding trends in management as treatment options have changed.
Objective: This study aimed to analyze trends in the surgical management of SUI, including slings and urethral bulking, from 2012 to 2022.
Obstet Gynecol Int
January 2025
Department of Gynecology and Obstetrics, Hotel Dieu de France Hospital, Beirut, Lebanon.
Pelvic organ prolapse (POP) is a benign condition that can adversely affect women's quality of life. Mesh sacrocolpopexy is an effective surgical treatment for POP, but is considered a complex and risky surgery for obese and elderly women. The objective of this study was to assess the impact of age and obesity on the outcomes of minimally invasive sacrocolpopexy.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!